Log in or Sign up for Free to view tailored content for your specialty!
Pediatric Cardiology News
Obesity increases risk for high BP in children
Children with excess weight or abdominal obesity at age 4 years had an increased risk for high BP after 2 years of follow-up, according to a study published in the European Journal of Preventive Cardiology.
Adolescent obesity may increase cardiomyopathy odds in adulthood
Adult men who had elevated body weight in adolescence may have elevated risk for cardiomyopathy, according to findings published in Circulation.
Log in or Sign up for Free to view tailored content for your specialty!
Physical activity in toddlerhood improves cardiovascular outcomes
Detrimental effects on cardiovascular health can begin at an early age, but research published in Pediatrics suggested that moderate-to-vigorous physical activity in childhood may slow this process.
Texas Children’s Hospital earns top pediatric cardiology, heart surgery ranking
For the third consecutive year, Texas Children’s Hospital received U.S. News & World Report’s No. 1 ranking as the best hospital for pediatric cardiology and heart surgery in the 2019-2020 Best Children’s Hospitals rankings.
Preterm, early birth may raise risk for ischemic heart disease in adulthood
Adults born preterm or early term have an increased risk for ischemic heart disease, according to findings published in JAMA Pediatrics.
FAMILIA
Researchers assessed the benefits of an early educational program focused on preschool-aged children.
Direct oral anticoagulant use in the pediatric population: Defining the path forward
On April 4, the Cardiac Safety Research Consortium held a think tank, titled “Non-vitamin K antagonist oral anticoagulants use in the pediatric population: Defining the path forward.”
Device to close atrial septal defects approved by FDA
W.L. Gore and Associates announced its occluder device was approved by the FDA for percutaneous closure of ostium secundum atrial septal defects.
NLA: Lp(a) can help assess ASCVD risk in several patient populations
MIAMI — A statement from the National Lipid Association focused on the standardization of lipoprotein(a) measurement, in addition to measuring Lp(a) to reclassify atherosclerotic CVD risk and to aid in decision making for pharmacotherapy, according to a presentation at the NLA Scientific Sessions.
FDA approves Fragmin, first anticoagulant for children
The FDA today approved dalteparin sodium injection to reduce the recurrence of symptomatic venous thromboembolism among children aged at least 1 month.